Negative transperineal template-guided saturation biopsy with serum PSA ≥30 μg/L: a report of 44 cases
10.3760/cma.j.issn.1000-6702.2012.07.007
- VernacularTitle:高PSA值而初次前列腺穿刺活检阴性44例临床分析
- Author:
Weigang YAN
;
Hanzhong LI
;
Zhigang JI
;
Yi ZHOU
;
Zhien ZHOU
;
Dachun ZHAO
;
Yu XIAO
;
Quancai CUI
- Publication Type:Journal Article
- Keywords:
Prostate specific antigen;
Biopsy;
Transperineal
- From:
Chinese Journal of Urology
2012;33(7):504-507
- CountryChina
- Language:Chinese
-
Abstract:
Objective To report outcomes of patients with PSA ≥ 30 μg/L with initial negative transperineal template-guided saturation biopsy (TTSB). Methods From 2003 to 2010,a total of 1824 patients underwent transperineal saturation biopsies with the prostate template at the Peking Union Medical College Hospital.44 of them had initial negative biopsy with PSA ≥ 30 μg/L were reviewed in this study.The mean age was 68 years old (range,51 to 80).The mean biopsy cores were 28.7 (range,11 to 44).The median PSA level was 40 μg/L (range,30 to 128),and the median prostate volume was 73 ml (range,30 to 190).They were divided into four groups:TURP group,chronic prostatitis group,repeat biopsy group and miscellaneous group. Results Patients were followed up for a mean of 49 months (range,12 to 91).All patients of TURP group (15 cases) were identified as prostatic hyperplasia by postoperative pathology.2 of them had a second TTSB for PSA ＞ 10 μg/L after TURP,which were negative.5 patients of chronic prostatitis group had a declining PSA level after antibiotic therapy for 3 to 4 weeks.One patient took a second biopsy,which was identified as prostatitis.All patients of repeat biopsy group (18 cases) showed no significant decrease in PSA level during follow-up and undertook biopsies 2 to 4 times,6 of which were proved to be prostate cancer.All patients of the miscellaneous group (6 cases) had a declining PSA and didn't take a second biopsy. Conclusions Close follow-up and regular PSA testing for patients who had a high PSA level with initial negative biopsy would be help to avoid both false negative of prostate cancer and unnecessary biopsy.
